TGFB1 and systemic sclerosis: Densitometric analysis of data obtained from three different experiments confirms that addition of recombinant CD109 protein results in a significant decrease in the production of TGF-β1-induced fibronectin, collagen type I and CCN2 in limited SSc and normal skin fibroblasts (Figure 5B).